Lara M. Munín Sánchez

Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients

María Currás-Freixes, Lucía Inglada‐Pérez, Veronika Mančíková et al. · Journal of Medical Genetics · 2015 · 127 citations · Full text

Life Sciences, Genetics, Oncology +17

Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy

María Apellániz-Ruiz, Miyoung Lee, Lara M. Munín Sánchez et al. · Clinical Cancer Research · 2014 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme

María Apellániz-Ruiz, Lucía Inglada‐Pérez, M.E.G. Naranjo et al. · The Pharmacogenomics Journal · 2014 · 66 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

p21WAF1/CIP1 AND MDM2 EXPRESSION IN NON-HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONS

Raquel Villuendas, Francesco Pezzella, Kevin C. Gatter et al. · The Journal of Pathology · 1997 · 62 citations

Medicine, Genetics, Oncology +14

Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

Lara M. Munín Sánchez, María Apellániz-Ruiz, Gerardo Gutiérrez‐Gutiérrez et al. · The Oncologist · 2018 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17